CochLear Operating Income 2023-2024 | CHEOY

CochLear annual/quarterly operating income history and growth rate from 2023 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • CochLear operating income for the quarter ending June 30, 2024 was $0M, a 0% increase year-over-year.
  • CochLear operating income for the twelve months ending June 30, 2024 was $0M, a 0% increase year-over-year.
  • CochLear annual operating income for 2024 was $0.312B, a 18.8% increase from 2023.
  • CochLear annual operating income for 2023 was $0.262B, a 9.64% decline from 2022.
  • CochLear annual operating income for 2022 was $0.29B, a 74.83% decline from 2021.
CochLear Annual Operating Income
(Millions of US $)
2024 $312
2023 $262
2022 $290
2021 $1,153
2020 $887
2019 $1,020
2018 $1,057
2017 $945
2016 $824
CochLear Quarterly Operating Income
(Millions of US $)
2024-06-30
2023-12-31
2023-06-30
2022-06-30
Sector Industry Market Cap Revenue
Medical Medical Services $11.550B $1.488B
Cochlear Limited provides implantable hearing solutions principally in the Americas, Europe, the Middle East, Africa and the Asia Pacific. The company offers cochlear implants, including Nucleus 7 and Kanso sound processors; Carina middle-ear implants and accessories and Baha bone conduction implants. Cochlear Limited is based in Sydney, Australia.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $143.614B 26.94
Elevance Health (ELV) United States $86.883B 11.21
CVS Health (CVS) United States $85.338B 10.61
Cencora (COR) United States $57.282B 19.93
DiDi Global (DIDIY) China $22.826B 24.25
Natera (NTRA) United States $22.577B 0.00
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.669B 0.00
Solventum (SOLV) United States $12.768B 13.52
ICON (ICLR) Ireland $11.763B 10.94
Revvity (RVTY) United States $11.024B 18.97
Doximity (DOCS) United States $10.503B 48.63
Viatris (VTRS) United States $10.469B 3.60
HealthEquity (HQY) United States $9.059B 39.68
Avantor (AVTR) United States $8.906B 12.94
Medpace Holdings (MEDP) United States $8.572B 22.77
Sonic Healthcare (SKHHY) Australia $8.393B 0.00
Charles River Laboratories (CRL) United States $7.340B 14.38
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.361B 25.69
BrightSpring Health Services (BTSG) United States $3.724B 34.16
Sotera Health (SHC) United States $3.244B 18.44
Alignment Healthcare (ALHC) United States $2.956B 0.00
Surgery Partners (SGRY) United States $2.914B 37.90
Concentras Parent (CON) United States $2.749B 15.89
Organon (OGN) United States $2.610B 2.77
Ardent Health (ARDT) United States $1.881B 8.02
Premier (PINC) United States $1.858B 14.11
GeneDx Holdings (WGS) United States $1.842B 70.96
Progyny (PGNY) United States $1.803B 39.68
PACS (PACS) United States $1.573B 0.00
GoodRx Holdings (GDRX) United States $1.561B 31.21
Teladoc Health (TDOC) United States $1.203B 0.00
Pediatrix Medical (MD) United States $1.203B 9.15
Establishment Labs Holdings (ESTA) $1.083B 0.00
CareDx (CDNA) United States $1.035B 16.17
Ryman Healthcare (RYHTY) New Zealand $1.011B 0.00
Agilon Health (AGL) United States $0.890B 0.00
AMN Healthcare Services Inc (AMN) United States $0.826B 7.73
QDM (QDMI) Hong Kong, SAR China $0.763B 0.00
Nutex Health (NUTX) United States $0.679B 10.28
LifeMD (LFMD) United States $0.566B 0.00
Embecta (EMBC) United States $0.559B 3.76
Enhabit (EHAB) United States $0.495B 40.75
InnovAge Holding (INNV) United States $0.478B 0.00
Auna S.A (AUNA) Luxembourg $0.467B 10.52
SBC Medicals (SBC) United States $0.459B 0.00
Sonida Senior Living (SNDA) United States $0.453B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.411B 0.00
Performant Healthcare (PHLT) United States $0.255B 0.00
Oncology Institute (TOI) United States $0.220B 0.00
Beauty Health (SKIN) United States $0.193B 0.00
KindlyMD (KDLY) United States $0.150B 0.00
DocGo (DCGO) United States $0.148B 24.17
Pheton Holdings (PTHL) China $0.114B 0.00
So-Young (SY) China $0.097B 0.00
KindlyMD (NAKA) United States $0.083B 0.00
OncoCyte (OCX) United States $0.076B 0.00
Sera Prognostics (SERA) United States $0.064B 0.00
Basel Medical Group (BMGL) Singapore $0.064B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
Ascend Wellness Holdings (AAWH) United States $0.060B 0.00
IceCure Medical (ICCM) Israel $0.054B 0.00
Biodesix (BDSX) United States $0.042B 0.00
ModivCare (MODV) United States $0.042B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.028B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
XWELL (XWEL) United States $0.005B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00